{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:18:14Z","timestamp":1787314694416,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["N01-CN-05229"],"award-info":[{"award-number":["N01-CN-05229"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["N01-PC-67008"],"award-info":[{"award-number":["N01-PC-67008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["N01-PC-35143"],"award-info":[{"award-number":["N01-PC-35143"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201000032C"],"award-info":[{"award-number":["HHSN261201000032C"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201300020I"],"award-info":[{"award-number":["HHSN261201300020I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011343","name":"Holden Comprehensive Cancer Center, University of Iowa","doi-asserted-by":"publisher","award":["P30 CA086862"],"award-info":[{"award-number":["P30 CA086862"]}],"id":[{"id":"10.13039\/100011343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10549-021-06495-y","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T19:05:01Z","timestamp":1642964701000},"page":"211-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000\u20132015"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-3936","authenticated-orcid":false,"given":"Danielle","family":"Riley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chrischilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M.","family":"Lizarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"6495_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"R Siegel","year":"2021","unstructured":"Siegel R, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. Ca Cancer J Clin 71:7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"Ca Cancer J Clin"},{"issue":"2","key":"6495_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","volume":"16","author":"B Fisher","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16(2):441\u2013452. https:\/\/doi.org\/10.1200\/JCO.1998.16.2.441","journal-title":"J Clin Oncol"},{"issue":"9169","key":"6495_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, Smith R, Begovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353(9169):1993\u20132000. https:\/\/doi.org\/10.1016\/S0140-6736(99)05036-9","journal-title":"Lancet"},{"issue":"9203","key":"6495_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/s0140-6736(99)06341-2","volume":"355","author":"JP Julien","year":"2000","unstructured":"Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355(9203):528\u2013533. https:\/\/doi.org\/10.1016\/s0140-6736(99)06341-2","journal-title":"Lancet"},{"issue":"21","key":"6495_CR5","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853\u2014a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381\u20133387. https:\/\/doi.org\/10.1200\/JCO.2006.06.1366","journal-title":"J Clin Oncol"},{"issue":"5","key":"6495_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/02841860600681569","volume":"45","author":"SO Emdin","year":"2006","unstructured":"Emdin SO, Granstrand B, Ringberg A, Sandelin K, Arnesson LG, Nordgren H, Anderson H, Garmo H, Holmberg L, Wallgren A, Swedish Breast Cancer Group (2006) SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast Results of a randomised trial in a population offered mammography screening. Acta Oncol 45(5):536\u2013543. https:\/\/doi.org\/10.1080\/02841860600681569","journal-title":"Acta Oncol"},{"issue":"9378","key":"6495_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0140-6736(03)13859-7","volume":"362","author":"J Houghton","year":"2003","unstructured":"Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M, UK Coordinating Committee on Cancer Research; Ductal Carcinoma in situ Working Party; DCIS trialists in the UK, Australia, and New Zealand (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362(9378):95\u2013102. https:\/\/doi.org\/10.1016\/s0140-6736(03)13859-7","journal-title":"Lancet"},{"key":"6495_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status and survival in 14,740 breast cancer cases. Cancer 63:181\u2013187. https:\/\/doi.org\/10.1002\/1097-0142(19890101)63:1%3c181::aid-cncr2820630129%3e3.0.co;2-h","journal-title":"Cancer"},{"key":"6495_CR9","unstructured":"National Comprehensive Cancer Network (NCCN) NCCN Guidelines Version 8.2021 Breast Cancer. Available at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed on 20 Sept 2021"},{"issue":"13","key":"6495_CR10","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1245\/s10434-015-4547-7","volume":"22","author":"AM Francis","year":"2015","unstructured":"Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK (2015) Is sentinel lymph node dissection warranted in patients with a diagnosis of ductal carcinoma in situ? Ann Surg Oncol 22(13):4270\u20134279. https:\/\/doi.org\/10.1245\/s10434-015-4547-7","journal-title":"Ann Surg Oncol"},{"key":"6495_CR11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/000313480106700419","volume":"67","author":"RF Brem","year":"2001","unstructured":"Brem RF, Schoonjans JM, Sanow L, Gatewood OMB (2001) Reliability of histologic diagnosis of breast cancer with stereotactic vacuum-assisted biopsy. Am Surg 67:388\u2013392","journal-title":"Am Surg"},{"key":"6495_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cursur.2004.09.011","volume":"62","author":"EA Mittendorf","year":"2005","unstructured":"Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD (2005) Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62:253\u2013257. https:\/\/doi.org\/10.1016\/j.cursur.2004.09.011","journal-title":"Curr Surg"},{"issue":"4","key":"6495_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.amjsurg.2005.06.011","volume":"190","author":"C Wilkie","year":"2005","unstructured":"Wilkie C, White L, Dupont E, Cantor A, Cox CE (2005) An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190(4):563\u2013566. https:\/\/doi.org\/10.1016\/j.amjsurg.2005.06.011","journal-title":"Am J Surg"},{"issue":"7","key":"6495_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jso.20445","volume":"93","author":"MF Dillon","year":"2006","unstructured":"Dillon MF, McDermott EW, Quinn CM, O\u2019Doherty A, O\u2019Higgins N, Hill ADK (2006) Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 93(7):559\u2013563. https:\/\/doi.org\/10.1002\/jso.20445","journal-title":"J Surg Oncol"},{"issue":"1","key":"6495_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, Houssami N (2011) ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260(1):119\u2013128. https:\/\/doi.org\/10.1148\/radiol.11102368","journal-title":"Radiology"},{"issue":"2","key":"6495_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.20892\/j.issn.2095-3941.2018.0159","volume":"16","author":"J Si","year":"2019","unstructured":"Si J, Yang B, Guo R, Huang N, Quan C, Ma L, Xiu B, Cao Y, Tang Y, Shen L, Chen J, Wu J (2019) Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy. Cancer Biol Med 16(2):312\u2013318. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2018.0159","journal-title":"Cancer Biol Med"},{"key":"6495_CR17","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE (2016) Sentinel lymph node biopsy for patients with early-stage breast cancer update (2016). Available at https:\/\/www.asco.org\/research-guidelines\/quality-guidelines\/guidelines\/breast-cancer#\/9801. Accessed on 20 Sept 2021"},{"issue":"3","key":"6495_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/jamaoncol.2015.0389","volume":"1","author":"EJ Coromilas","year":"2015","unstructured":"Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Chen L, Herman DL (2015) The influence of hospital and surgeon factors on the prevalence of axillary lymph node evaluation in ductal carcinoma in situ. JAMA Oncol 1(3):323\u2013332. https:\/\/doi.org\/10.1001\/jamaoncol.2015.0389","journal-title":"JAMA Oncol"},{"issue":"1","key":"6495_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12893-017-0210-5","volume":"17","author":"KB Mitchell","year":"2017","unstructured":"Mitchell KB, Lin H, Colfry A, Kuerer H, Shaitelman SF, Babiera GV, Bedrosian I (2017) DCIS and axillary nodal evaluation: compliance with national guidelines. BMC Surg 17(1):12. https:\/\/doi.org\/10.1186\/s12893-017-0210-5","journal-title":"BMC Surg"},{"issue":"9","key":"6495_CR20","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1245\/s10434-020-08374-0","volume":"27","author":"BJ Pyfer","year":"2020","unstructured":"Pyfer BJ, Jonczyk M, Jean J, Graham RA, Chen L, Chatterjee A (2020) Analysis of surgical trends for axillary lymph node management in patients with ductal carcinoma in situ using the NSQIP database: are we following national guidelines? Ann Surg Oncol 27(9):3448\u20133455. https:\/\/doi.org\/10.1245\/s10434-020-08374-0","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6495_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1245\/s10434-012-2539-4","volume":"20","author":"DR Shah","year":"2013","unstructured":"Shah DR, Canter RJ, Khatri VP, Bold RJ, Yang AD, Martinez SR (2013) Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol 20(1):24\u201330. https:\/\/doi.org\/10.1245\/s10434-012-2539-4","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6495_CR22","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jss.2012.03.015","volume":"177","author":"DR Shah","year":"2012","unstructured":"Shah DR, Canter RJ, Khatri VP, Bold RJ, Martinez SR (2012) Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res 177(1):e21-26. https:\/\/doi.org\/10.1016\/j.jss.2012.03.015","journal-title":"J Surg Res"},{"key":"6495_CR23","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1245\/s10434-016-5322-0","volume":"23","author":"ME Miller","year":"2016","unstructured":"Miller ME, Kyrillos A, Yao K, Kantor O, Tseng J, Winchester DJ, Shulman LN (2016) Utilization of axillary surgery for patients with ductal carcinoma in situ: a report from the national cancer data base. Ann Surg Oncol 23:3337\u20133346. https:\/\/doi.org\/10.1245\/s10434-016-5322-0","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"6495_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cncr.23229","volume":"112","author":"T Onega","year":"2008","unstructured":"Onega T, Duell E, Shi X, Wang D, Demidenko E, Goodman D (2008) Geographic access to cancer care in the U.S. Cancer 112(4):909\u2013918. https:\/\/doi.org\/10.1002\/cncr.23229","journal-title":"Cancer"},{"issue":"6","key":"6495_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","volume":"129","author":"N Douthit","year":"2015","unstructured":"Douthit N, Kiv S, Dwolatzky T, Biswas S (2015) Exposing some important barriers to health care access in the rural USA. Public Health 129(6):611\u2013620. https:\/\/doi.org\/10.1016\/j.puhe.2015.04.001","journal-title":"Public Health"},{"issue":"10","key":"6495_CR26","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1158\/1055-9965.epi-13-0404","volume":"22","author":"A Meilleur","year":"2013","unstructured":"Meilleur A, Subramaniam S, Plascak J, Fisher J, Paskett E, Lamont E (2013) Rural residence and cancer outcomes in the United States: issues and challenges. Cancer Epidemiol Biomarkers Prev 22(10):1657\u20131667. https:\/\/doi.org\/10.1158\/1055-9965.epi-13-0404","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6495_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-18408-7_16","volume-title":"Geospatial approaches to energy balance and breast cancer","author":"S McLafferty","year":"2019","unstructured":"McLafferty S (2019) Rural\u2013urban disparities in breast cancer: six suppositions and future directions. Geospatial approaches to energy balance and breast cancer. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-18408-7_16"},{"issue":"5","key":"6495_CR28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.amjsurg.2013.07.007","volume":"206","author":"AK Arrington","year":"2013","unstructured":"Arrington AK, Kruper L, Vito C, Yim J, Kim J, Chen SL (2013) Rural and urban disparities in the evolution of sentinel lymph node utilization in breast cancer. Am J Surg 206(5):674\u2013681. https:\/\/doi.org\/10.1016\/j.amjsurg.2013.07.007","journal-title":"Am J Surg"},{"issue":"3","key":"6495_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","volume":"16","author":"J Rescigno","year":"2009","unstructured":"Rescigno J, Zampell JC, Axelrod D (2009) Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol 16(3):687\u2013696. https:\/\/doi.org\/10.1245\/s10434-008-0195-5","journal-title":"Ann Surg Oncol"},{"issue":"31","key":"6495_CR30","doi-asserted-by":"publisher","first-page":"e4392","DOI":"10.1097\/MD.0000000000004392","volume":"95","author":"TW Yen","year":"2016","unstructured":"Yen TW, Li J, Sparapani RA, Laud PW, Nattinger AB (2016) The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer. Medicine (Baltimore) 95(31):e4392. https:\/\/doi.org\/10.1097\/MD.0000000000004392","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"6495_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.amjsurg.2020.01.014","volume":"220","author":"TA James","year":"2020","unstructured":"James TA, Palis B, McCabe R, Pardo JA, Alapati A, Ukandu O, Serres SK, Zhang J, Mele A, Facktor M, Shulman LN (2020) Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery. Am J Surg 220(3):654\u2013659. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.01.014","journal-title":"Am J Surg"},{"issue":"5","key":"6495_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","volume":"34","author":"P Del Bianco","year":"2008","unstructured":"Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecararo P, Belardinelli V, De Salvo G, GIVOM (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34(5):508\u2013513. https:\/\/doi.org\/10.1016\/j.ejso.2007.05.017","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"6495_CR33","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1245\/s10434-008-9909-y","volume":"15","author":"R Crane-Okada","year":"2008","unstructured":"Crane-Okada R, Wascher R, Elashoff D, Giuliano A (2008) Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 15(7):1996\u20132005. https:\/\/doi.org\/10.1245\/s10434-008-9909-y","journal-title":"Ann Surg Oncol"},{"key":"6495_CR34","unstructured":"Surveillance, epidemiology, and end results program. Overview of the SEER Program. National Cancer Institute. Available at https:\/\/seer.cancer.gov\/about\/overview.html. Accessed on 20 Sept 2021"},{"key":"6495_CR35","unstructured":"National Cancer Institute, Division of Cancer Control & Population Sciences, Healthcare Delivery Research Program. Patterns of Care Studies. Available at https:\/\/healthcaredelivery.cancer.gov\/poc\/. Accessed on 20 Sept 2021"},{"key":"6495_CR36","unstructured":"National Cancer Institute, Division of Cancer Control and Population Sciences and Division of Cancer Treatment and Diagnosis, Surveillance, Epidemiology, and End Results Program (1991, 1995, 2000, 2005, 2010, 2015) Breast Cancer Data Set. POC Data Acquisition Manual."},{"issue":"3","key":"6495_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","volume":"95","author":"A Fleissig","year":"2006","unstructured":"Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279\u2013293. https:\/\/doi.org\/10.1007\/s10549-005-9025-7","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6495_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/cncr.23514","volume":"113","author":"M Yi","year":"2008","unstructured":"Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK (2008) How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 113(1):30\u201337. https:\/\/doi.org\/10.1002\/cncr.23514","journal-title":"Cancer"},{"key":"6495_CR39","unstructured":"USDA Rural\u2013Urban Continuum Codes. Available at https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes\/. Accessed on 20 Sept 2021"},{"key":"6495_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"1","key":"6495_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1468-0009.2005.00428.x","volume":"51","author":"R Andersen","year":"1973","unstructured":"Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health 51(1):95\u2013124. https:\/\/doi.org\/10.1111\/j.1468-0009.2005.00428.x","journal-title":"Milbank Mem Fund Q Health"},{"issue":"1","key":"6495_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/jayao.2016.0028","volume":"6","author":"J Clemons","year":"2017","unstructured":"Clemons J, Zahnd WE, Nutt M, Sadowski D, Dynda D, Alanee S (2017) Impact of urologist density and county rurality on the practice of retroperitoneal lymph node dissection and cancer-specific death in patients with nonseminomatous germ cell tumors. J Adolesc Young Adult Oncol 6(1):83\u201390. https:\/\/doi.org\/10.1089\/jayao.2016.0028","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"12","key":"6495_CR43","doi-asserted-by":"publisher","first-page":"504.e9","DOI":"10.1016\/j.urolonc.2015.07.015","volume":"33","author":"AP Cole","year":"2015","unstructured":"Cole AP, Dalela D, Hanske J, Mullane SA, Choueiri TK, Meyer CP, Nguyen PL, Menon M, Kibel AS, Preston MA, Bellmunt J, Trinh QD (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33(12):504.e9\u201317. https:\/\/doi.org\/10.1016\/j.urolonc.2015.07.015","journal-title":"Urol Oncol"},{"issue":"4","key":"6495_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/DCR.0000000000000173","volume":"58","author":"CJ Chow","year":"2015","unstructured":"Chow CJ, Al-Refaie WB, Abraham A, Markin A, Zhong W, Rothenberger DA, Kwaan MR, Habermann EB (2015) Does patient rurality predict quality colon cancer care?: A population-based study. Dis Colon Rectum 58(4):415\u2013422. https:\/\/doi.org\/10.1097\/DCR.0000000000000173","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"6495_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10552-017-0998-4","volume":"29","author":"WE Zahnd","year":"2018","unstructured":"Zahnd WE, Hyon KS, Diaz-Sylvester P, Izadi SR, Colditz GA, Brard L (2018) Rural-urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients. Cancer Causes Control 29(2):221\u2013232. https:\/\/doi.org\/10.1007\/s10552-017-0998-4","journal-title":"Cancer Causes Control"},{"issue":"8","key":"6495_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamasurg.2014.23","volume":"149","author":"DM Black","year":"2014","unstructured":"Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD (2014) Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg 149(8):788\u2013796. https:\/\/doi.org\/10.1001\/jamasurg.2014.23","journal-title":"JAMA Surg"},{"issue":"7","key":"6495_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/jnci\/djn057","volume":"100","author":"AY Chen","year":"2008","unstructured":"Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E (2008) Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998\u20132005). J Natl Cancer Inst 100(7):462\u2013474. https:\/\/doi.org\/10.1093\/jnci\/djn057","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"6495_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","volume":"34","author":"P Del Bianco","year":"2008","unstructured":"Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL, GIVOM (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34(5):508\u2013513. https:\/\/doi.org\/10.1016\/j.ejso.2007.05.017","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"6495_CR49","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1245\/s10434-019-07323-w","volume":"26","author":"LN Shulman","year":"2019","unstructured":"Shulman LN, Browner AE, Palis BE, Mallin K, Kakade S, Carp N, McCabe R, Winchester D, Wong SL, McKellar DP (2019) Compliance with cancer quality measures over time and their association with survival outcomes: the commission on cancer\u2019s experience with the quality measure requiring at least 12 regional lymph nodes to be removed and analyzed with colon cancer resections. Ann Surg Oncol 26(6):1613\u20131621. https:\/\/doi.org\/10.1245\/s10434-019-07323-w","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"6495_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","volume":"200","author":"TW Yen","year":"2005","unstructured":"Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516\u2013526. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2004.11.012","journal-title":"J Am Coll Surg"},{"issue":"3","key":"6495_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1524-4741.2007.00418.x","volume":"13","author":"LA Rutstein","year":"2007","unstructured":"Rutstein LA, Johnson RR, Poller WR, Dabbs D, Groblewski J, Rakitt T, Tsung A, Kirchner T, Sumkin J, Keenan D, Soran A, Ahrendt G, Falk JS (2007) Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J 13(3):251\u2013257. https:\/\/doi.org\/10.1111\/j.1524-4741.2007.00418.x","journal-title":"Breast J"},{"issue":"3","key":"6495_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1524-4741.2011.01069.x","volume":"17","author":"JS Han","year":"2011","unstructured":"Han JS, Molberg KH, Sarode V (2011) Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Breast J 17(3):223\u2013229. https:\/\/doi.org\/10.1111\/j.1524-4741.2011.01069.x","journal-title":"Breast J"},{"issue":"3","key":"6495_CR53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","volume":"98","author":"A Goyal","year":"2006","unstructured":"Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98(3):311\u2013314. https:\/\/doi.org\/10.1007\/s10549-006-9167-2","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6495_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-021-06105-x","volume":"188","author":"IM Lizarraga","year":"2021","unstructured":"Lizarraga IM, Kahl AR, Jacoby E, Charlton ME, Lynch CF, Sugg SL (2021) Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study. Breast Cancer Res Treat 188(1):191\u2013202. https:\/\/doi.org\/10.1007\/s10549-021-06105-x","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"6495_CR55","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"issue":"19","key":"6495_CR56","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","volume":"23","author":"AD Purushotham","year":"2005","unstructured":"Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23(19):4312\u20134321. https:\/\/doi.org\/10.1200\/JCO.2005.03.228","journal-title":"J Clin Oncol"},{"key":"6495_CR57","unstructured":"United States Department of Agriculture Economic Research Service (2016) Economic Information Bulletin 162. Available at https:\/\/www.ers.usda.gov\/webdocs\/publications\/80894\/eib-162.pdf. Accessed on 20 Sept 2021"},{"issue":"2","key":"6495_CR58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11524-005-9016-3","volume":"83","author":"SA Hall","year":"2006","unstructured":"Hall SA, Kaufman JS, Ricketts TC (2006) Defining urban and rural areas in U.S. epidemiologic studies. J Urban Health 83(2):162\u2013175. https:\/\/doi.org\/10.1007\/s11524-005-9016-3","journal-title":"J Urban Health"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06495-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06495-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06495-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T02:36:27Z","timestamp":1674527787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06495-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6495"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06495-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Waived by the Institutional Review Board of the University of Iowa due to the observational nature of the study design and use of de-identifiable data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The manuscript was submitted to the NCI POC contact and approved for publication. All authors have read the paper and consent to its publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}